XML 21 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation
9 Months Ended
Sep. 30, 2022
Stock-Based Compensation [Abstract]  
Stock-Based Compensation 4.           Stock-Based Compensation

During the nine-month period ended September 30, 2022, no stock options were granted. As of September 30, 2022, there was $67,000 of total unrecognized compensation cost related to non-vested options granted in 2021 under the 2014 Equity Incentive Plan, which will be fully amortized by December 31, 2022. Compensation costs related to stock options amounted to $201,000 and $160,000 during the nine-month periods ended September 30, 2022 and 2021, respectively.

A summary of the Company’s stock option activity for the nine-month period ended September 30, 2022 is as follows:

Weighted

Average Exercise

Weighted Average

Aggregate

Price

Remaining

Intrinsic Value

Options

Per Share

Contractual Term

($000)

Outstanding at January 1, 2022

226,075

$

26.37

6.4

Yrs.

$

520

Granted

-

-

Exercised

(21,600)

18.49

1.0

Forfeited

-

-

Outstanding at September 30, 2022

204,475

$

27.20

6.1

Yrs.

$

380

Exercisable at September 30, 2022

162,975

$

27.56

5.3

Yrs.

$

380

Intrinsic value represents the amount by which the market price of the stock on the measurement date exceeded the exercise price of the option. The market price was $26.58 per share as of September 30, 2022 and $25.99 per share as of December 31, 2021.

A summary of the Company’s restricted stock activity for the nine-month periods ended September 30, 2022 and 2021 is as follows:

2022

2021

Weighted-Average

Weighted-Average

Number of

Grant Date

Number of

Grant Date

Restricted Stock

Fair Value

Restricted Stock

Fair Value

Non-vested, January 1,

32,030

$

29.76

39,135

$

30.72

Granted

7,500

25.71

Vested

Forfeited

(3,900)

30.86

Non-vested, September 30,

39,530

$

28.99

35,235

$

30.71

The expected future compensation expense relating to the 39,530 shares of non-vested restricted stock outstanding as of September 30, 2022 is $875,000. This cost will be recognized over the remaining vesting period of 4.25 years. Compensation costs related to restricted stock amounted to $272,000 and $251,000 during the nine-month periods ended September 30, 2022 and 2021, respectively.